Actively Recruiting

Phase Not Applicable
Age: 18Years - 40Years
FEMALE
Healthy Volunteers
ID07258576

The Effect of Menstrual Cycle Phase and Oral Contraceptive Use on Muscle Protein Metabolism Post-Resistance Training

Led by University of Toronto · Updated on 2025-12-02

20

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are investigating how menstrual cycle phases and the use of oral contraceptives affect muscle protein synthesis after resistance exercise in females aged 18 to 40 years. This study aims to improve understanding of protein metabolism influenced by female sex hormones such as estrogen and progesterone, which have often led to exclusion of females in past research due to assumed variability. The findings will help develop better training and nutrition advice tailored for females. Participants will be randomly assigned to one of four groups representing different menstrual or contraceptive phases: mid-luteal phase, early follicular phase, active pill phase, or placebo pill phase. They will consume protein beverages enriched with stable isotope tracers ([D5]phenylalanine and [13C]phenylalanine) over an 8-hour period to measure muscle and whole-body protein synthesis. The study includes resistance exercise sessions and precise timing related to menstrual or contraceptive cycles. During the trial, participants will undergo tests including muscle protein synthesis measurement over 8 hours and whole-body protein synthesis over 4 hours. Researchers will monitor progesterone levels and dietary intake and evaluate the effects of resistance training combined with protein consumption. The study includes safety checks and assessments related to hormonal status, with participation lasting throughout the assigned menstrual or contraceptive phase timing.

CONDITIONS

Brief Title

Menstrual Cycle vs. Oral Contraceptives: Effects on Muscle Protein Metabolism After Resistance Exercise

Who Can Participate

Age: 18Years - 40Years
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Female aged 18 to 40 years
  • Body mass index between 18.5 and 29.9 kg/m2
  • Recreationally active, resistance training at least twice weekly
  • Using monophasic or triphasic oral contraceptives for more than 1 year (oral contraceptive users)
  • Regular menstrual cycles (21-35 days) for past 3 months and no hormonal contraceptive use for at least 6 months (non-oral contraceptive users)
  • Meet progesterone sufficiency test (non-oral contraceptive users)
Not Eligible

You will not qualify if you...

  • Mid-luteal progesterone levels below 16 umol
  • Diagnosed chronic diseases such as cardiovascular, thyroid, or diabetes
  • Current or recent remission of cancer
  • Regular use of NSAIDs (non-steroidal anti-inflammatory drugs) except low-dose aspirin, or anticoagulants
  • Use of prescription drugs affecting muscle protein synthesis (e.g., statins, lithium, ADHD medication)
  • Use of intrauterine device (IUD), except copper IUD
  • Use of emergency contraception in the last 3 months
  • Severe food allergies such as soy or nuts
  • Smoking or use of performance-enhancing drugs like growth hormones or testosterone

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Each intervention phase lasts several days based on menstrual or pill cycle timing

Participants will consume protein beverages enriched with stable isotope tracers during different phases of the menstrual cycle or oral contraceptive use to assess muscle protein metabolism after resistance exercise.

Several visits scheduled according to menstrual and pill cycle phases

Trial Site Locations

Total: 1 location

1

Goldring Center for High Performance Sport

Toronto, Ontario, Canada, M5S 2C9

Actively Recruiting

Loading map...

Research Team

D

Daniel R Moore, PhD

I

Ines Kortebi, PhD Candidate

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

BASIC_SCIENCE

Number of Arms

4

Similar Trials

Amino Acid Oxidation of Whole-Food Protein: a Dose-Response ...

Protein Metabolism

Actively Recruiting

1 location

Anabolic Response to Beef vs Plant Protein in (Pre)Frail Old...

Protein Metabolism

Actively Recruiting

1 location

The Effects of Animal- and Microbial-based Protein Sources o...

Protein Metabolism

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here